Hillstar Bio Funding: $67M Raised, Series A (2025)
Hillstar Bio is based in Boston, MA. It has raised $67M in total funding. Latest round: Series A.
Hillstar Bio funding overview
Hillstar Bio is based in Boston, MA. Hillstar Bio has raised $67M in total disclosed funding. That places its disclosed total in the $25M–$100M range. Its most recent disclosed round is a Series A announced in March 2025. The round record for Hillstar Bio runs through 2025; nothing later has been disclosed. Investors on record include Droia Ventures, Frazier Life Sciences, Novo Holdings A/S, LifeArc Ventures, Hummingbird Bioscience. 5 distinct backers are named across the disclosed rounds.
Hillstar Bio at a glance
Total raised
$67M
Latest round
Series A
Latest round date
March 2025
Headquarters
Boston, MA
Notable investors
Droia Ventures, Frazier Life Sciences, Novo Holdings A/S, LifeArc Ventures, Hummingbird Bioscience
Frequently asked about Hillstar Bio funding
How much has Hillstar Bio raised?
Hillstar Bio has raised $67M in total disclosed funding across the rounds on record.
Who has invested in Hillstar Bio?
Droia Ventures, Frazier Life Sciences, Novo Holdings A/S, LifeArc Ventures, Hummingbird Bioscience are named among the investors backing Hillstar Bio.
What was the latest Hillstar Bio funding round?
The most recent disclosed round is a Series A, announced in March 2025.
Where is Hillstar Bio based?
Hillstar Bio is based in Boston, MA.
When did Hillstar Bio last raise?
The last disclosed Hillstar Bio round closed in March 2025 at Series A.
Hillstar Bio totals reflect disclosed capital only — undisclosed extensions and secondaries are excluded. Use the related companies in Boston below to benchmark round size and investor mix.
